Literature DB >> 17707664

Matrix metalloproteinases as modulators of inflammation.

Anne M Manicone1, John K McGuire.   

Abstract

An increased expression of members of the matrix metalloproteinase (MMP) family of enzymes is seen in almost every human tissue in which inflammation is present. Through the use of models of human disease in mice with targeted deletions of individual MMPs, it has become clear that MMPs act broadly in inflammation to regulate barrier function, inflammatory cytokine and chemokine activity, and the generation of chemokine gradients. Individual MMPs regulate both normal and pathological inflammatory processes, and therefore, developing rational therapies requires further identification of specific MMP substrates and characterization of the downstream consequences of MMP proteolytic activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707664      PMCID: PMC2235912          DOI: 10.1016/j.semcdb.2007.07.003

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  84 in total

1.  The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).

Authors:  S Maeda; D D Dean; R Gomez; Z Schwartz; B D Boyan
Journal:  Calcif Tissue Int       Date:  2001-12-21       Impact factor: 4.333

2.  Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency.

Authors:  David B Corry; Kirtee Rishi; John Kanellis; Attila Kiss; Li-zhen Song Lz; Jie Xu; Lili Feng; Zena Werb; Farrah Kheradmand
Journal:  Nat Immunol       Date:  2002-03-11       Impact factor: 25.606

3.  Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin.

Authors:  Gudrun Ratzinger; Patrizia Stoitzner; Susanne Ebner; Manfred B Lutz; Guy T Layton; Christian Rainer; Robert M Senior; J Michael Shipley; Peter Fritsch; Gerold Schuler; Nikolaus Romani
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

4.  Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.

Authors:  Didier D Cataldo; Kurt G Tournoy; Karim Vermaelen; Carine Munaut; Jean-Michel Foidart; Renaud Louis; Agnès Noël; Romain A Pauwels
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  Gelatinase B deficiency protects against endotoxin shock.

Authors:  Bénédicte Dubois; Sofie Starckx; Axel Pagenstecher; Joost van den Oord; Bernd Arnold; Ghislain Opdenakker
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

Review 6.  Matrix metalloproteinases in neuroinflammation.

Authors:  Gary A Rosenberg
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

7.  Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.

Authors:  G Angus McQuibban; Jiang-Hong Gong; Julie P Wong; John L Wallace; Ian Clark-Lewis; Christopher M Overall
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

8.  The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity.

Authors:  Mohita J Mohan; Theresa Seaton; Justin Mitchell; Anne Howe; Kevin Blackburn; William Burkhart; Mary Moyer; Inder Patel; Gregory M Waitt; J David Becherer; Marcia L Moss; Marcos E Milla
Journal:  Biochemistry       Date:  2002-07-30       Impact factor: 3.162

9.  Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling.

Authors:  Sophie Lanone; Tao Zheng; Zhou Zhu; Wei Liu; Chun Geun Lee; Bing Ma; Qingsheng Chen; Robert J Homer; Jingming Wang; Lesley A Rabach; Morgan E Rabach; J Michael Shipley; Steven D Shapiro; Robert M Senior; Jack A Elias
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

10.  The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis.

Authors:  Takeshi Itoh; Hidetoshi Matsuda; Masatoshi Tanioka; Kenji Kuwabara; Shigeyoshi Itohara; Ryuji Suzuki
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  160 in total

1.  Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice.

Authors:  Lei Ding; Zhe Lu; Oded Foreman; Rodney Tatum; Qun Lu; Randall Renegar; Jian Cao; Yan-Hua Chen
Journal:  Gastroenterology       Date:  2011-10-29       Impact factor: 22.682

2.  Role of matrix metalloproteinase-8 as a mediator of injury in intestinal ischemia and reperfusion.

Authors:  Meghan C Daly; Sarah J Atkinson; Brian M Varisco; Lindsey Klingbeil; Paul Hake; Patrick Lahni; Giovanna Piraino; David Wu; Simon P Hogan; Basilia Zingarelli; Hector R Wong
Journal:  FASEB J       Date:  2016-07-19       Impact factor: 5.191

3.  Endothelial MMP-9 drives the inflammatory response in abdominal aortic aneurysm (AAA).

Authors:  Martina Ramella; Francesca Boccafoschi; Kevin Bellofatto; Antonia Follenzi; Luca Fusaro; Renzo Boldorini; Francesco Casella; Carla Porta; Piergiorgio Settembrini; Mario Cannas
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

4.  Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia.

Authors:  Anne M Manicone; Timothy P Birkland; Michelle Lin; Tomoko Betsuyaku; Nico van Rooijen; Jouko Lohi; Jorma Keski-Oja; Ying Wang; Shawn J Skerrett; William C Parks
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

5.  Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma.

Authors:  Cong Hua; Gang Zhao; Yan Feng; Hongyan Yuan; Hongmei Song; Li Bie
Journal:  J Neurotrauma       Date:  2015-08-06       Impact factor: 5.269

6.  Matrix metalloproteinase expression is altered in the small and large intestine following fractionated radiation in vivo.

Authors:  Romany L Stansborough; Noor Al-Dasooqi; Emma H Bateman; Joanne M Bowen; Dorothy M K Keefe; Richard M Logan; Ann S J Yeoh; Eric E K Yeoh; Andrea M Stringer; Rachel J Gibson
Journal:  Support Care Cancer       Date:  2018-05-12       Impact factor: 3.603

7.  Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development.

Authors:  C B Little; A Barai; D Burkhardt; S M Smith; A J Fosang; Z Werb; M Shah; E W Thompson
Journal:  Arthritis Rheum       Date:  2009-12

8.  Matrix Metalloproteinases Expressed in Response to Bacterial Vaginosis Disrupt the Endocervical Epithelium, Increasing Transmigration of HIV.

Authors:  Michelle D Cherne; Amy L Cole; Lisa Newberry; Mary Schmidt-Owens; Michael Deichen; Alexander M Cole
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 9.  Tumor stroma as targets for cancer therapy.

Authors:  Jing Zhang; Jinsong Liu
Journal:  Pharmacol Ther       Date:  2012-10-12       Impact factor: 12.310

Review 10.  Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review.

Authors:  Giuseppina Palladini; Andrea Ferrigno; Plinio Richelmi; Stefano Perlini; Mariapia Vairetti
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.